R&D Systems™ Recombinant Human IL-17RB Fc Chimera Protein, CF
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Manufacturer: R&D Systems™ 1207BR050
DescriptionThe Recombinant Human IL-17 RB Fc Chimera Protein is derived from NS0. The Recombinant Human IL-17 RB Fc Chimera Protein has been validated for the following applications: Binding Activity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|57 kDa (monomer)|
|90%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line,NS0-derived human IL-17 RB protein, (N-terminus) Human IL-17 RB (Arg18-Gly289) Accession &Num; NP_061195 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|CRL4IL-17 receptor homolog 1, cytokine receptor CRL4, Cytokine receptor-like 4, Evi27, EVI27IL-17B receptor, IL-17 RB, IL-17 receptor B, IL-17 RH1, IL17BRinterleukin 17B receptor, IL-17ER, IL17RB, IL-17RB, IL17Rh1, IL-17Rh1, IL17RH1MGC5245, interleukin 17 receptor B, interleukin 17 receptor homolog 1, interleukin-17 receptor B, Interleukin-17B receptor|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok